Medical Treatment & Drug Development
Bacteria & Other Microorganisms
Antimicrobials, Antibiotics & Drug Resistances
Biotech- and Nanotechnology
Post-Doctoral Fellowships
Israel
Studying multi-drug resistance implications of the 'excludon', a novel antisense-based regulatory structure in bacteria
Getting the Better of Antibiotic Resistance
To add or modify information on this page, please contact us at the following address: community.research@axa.com
 Ofir
 COHEN 
Institution
Weizmann Institute of Science
Country
Israel
Nationality
Israeli
Related articles
Chronic & Non-communicable Diseases
Medical Treatment & Drug Development
Chronic Pain & Musculoskeletal Disorders
Drug Delivery
Biotech- and Nanotechnology
AXA Project
France
Pain Pediatric & Elderly AXA Research Lab (PEARL)
Chronic pain is recognized as a major public health problem affecting patients in their daily activity, physical and mental health,... Read more
 Celine
 GRECO 
Hôpital Necker-Enfants Malades
Medical Treatment & Drug Development
Drug Delivery
Biotech- and Nanotechnology
Mécénat des Mutuelle
France
Accelerating drug innovation with the Euridis school and its DDD Challenge
The project addresses a dual challenge: on one hand, the increasing complexity of drug development, which requires a thorough understanding... Read more
 Laurence
 SABATIER 
Institut du médicament de Strasbourg
Medical Treatment & Drug Development
Antimicrobials, Antibiotics & Drug Resistances
Bacteria & Other Microorganisms
Drug Delivery
Mécénat des Mutuelle
France
New Molecule to Combat Antibiotic-Resistant Childhood Sepsis
The global spread of antibiotic resistance requires the identification of new bacterial drug targets, the design and synthesis of innovative... Read more
 Nalini
 RAMA RAO